Mounjaro(Tirzepatide)
The most advanced weight loss medication available. Mounjaro works on dual hormone pathways to deliver exceptional results with up to 23% body weight reduction.
Up to 23%
Weight Loss
Once Weekly
Easy Dosing
Dual Action
GIP + GLP-1
FDA Approved
Safe & Proven
How Mounjaro Works
Mounjaro (tirzepatide) is a breakthrough dual-action medication that activates both GIP and GLP-1 receptors.
Reduces Appetite
Signals your brain to feel fuller for longer, naturally reducing food intake and cravings.
Slows Gastric Emptying
Keeps food in your stomach longer, helping you stay satisfied between meals.
Improves Insulin Sensitivity
Enhances your body's ability to use insulin effectively, supporting better blood sugar control.
Increases Energy Expenditure
Helps your body burn more calories naturally, supporting sustainable weight loss.
Clinical Results
In clinical trials, patients taking Mounjaro experienced:
- Average 22.5% body weight reduction at the highest dose over 72 weeks
- 91% of participants lost 5% or more of their body weight
- Significant improvements in blood sugar, blood pressure, and cholesterol levels
Who Is Eligible?
Mounjaro may be suitable if you:
- Have a BMI of 27 or higher with weight-related health conditions
- Have a BMI of 30 or higher
- Are committed to lifestyle changes including diet and exercise
- Have tried other weight loss methods without success
Important: Mounjaro is not suitable for everyone. Our medical team will assess your full medical history to determine if this treatment is right for you.
Side Effects & Safety Information
Common Side Effects
Most side effects are mild to moderate and typically improve as your body adjusts to the medication:
- Nausea
- Diarrhoea
- Decreased appetite
- Vomiting
- Constipation
- Abdominal pain
- Indigestion
- Injection site reactions
Serious Side Effects - Seek Medical Attention
- • Severe abdominal pain (possible pancreatitis)
- • Vision changes
- • Signs of kidney problems (changes in urination)
- • Severe allergic reactions (rash, swelling, difficulty breathing)
- • Signs of thyroid tumours (lump in neck, hoarseness, difficulty swallowing)
Important Safety Information
- • Do not use if you have a personal or family history of medullary thyroid cancer
- • Inform your doctor if you have a history of pancreatitis
- • May increase risk of hypoglycaemia when used with other diabetes medications
- • Not recommended during pregnancy or breastfeeding
Dosing & Administration
Standard Dosing Schedule
Mounjaro is gradually increased to minimise side effects and optimise results:
Weeks 1-4: 2.5mg once weekly
Starting dose to assess tolerance
Weeks 5-8: 5mg once weekly
First dose increase
Week 9+: Gradual increases to 10mg or 15mg
Maintenance dose based on individual response
How to Inject
- Inject once weekly on the same day each week
- Can be taken with or without food
- Inject into abdomen, thigh, or upper arm
- Rotate injection sites to prevent irritation
Frequently Asked Questions
Ready to Start Your Journey?
Take our health assessment to see if Mounjaro is right for you.